RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253151

FDA DEVICE FACTS

Fule Interbody Fusion Cage System

Beijing Fule Science & Technology Development Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 15, 2026PRODUCT CODEMAX

Indications for use

Cervical Device Cervical Spine (C2-T1): The FULE Interbody Fusion Cage Systems are indicated for use as intervertebral body fusion devices in skeletally mature patients with degenerative disc disease (DDD), defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies, at one level of the cervical spine with accompanying radicular symptoms. Patients should have undergone at least six weeks of non-operative treatment prior to surgery. The implants are intended to facilitate fusion in the cervical spine (C2-T1) and are placed via an anterior cervical approach, using autogenous bone graft. When used in the cervical spine, the FULE Interbody Fusion Cage Systems are not intended for stand-alone use and must be used with supplemental fixation systems that have been cleared by FDA for use in the cervical spine, such as anterior cervical plate and screw fixation systems. Lumbar Devices Lumbar Spine (L2-S1): The FULE Interbody Fusion Cage Systems are indicated for use as intervertebral body fusion devices in skeletally mature patients with degenerative disc disease (DDD), defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies, at one or two contiguous levels of the lumbar spine (L2-S1). Patients should have undergone at least six months of non-operative treatment prior to surgery. These implants are intended to facilitate fusion in the lumbar spine and are placed via an oblique lumbar interbody fusion (OLIF), posterior lumbar interbody fusion (PLIF), or transforaminal lumbar interbody fusion (TLIF) approach, using autograft or allograft bone graft. When used in the lumbar spine, the FULE Interbody Fusion Cage Systems are not intended for stand-alone use and must be used with supplemental fixation systems that have been cleared by FDA for use in the lumbar/lumbosacral spine, such as posterior pedicle screw and rod fixation systems.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026